Infectious Diseases

Eur Rev Med Pharmacol Sci 2020; 24 (12): 6484-6485
DOI: 10.26355/eurrev_202006_21630

The hemagglutinin-esterase gene in human coronaviruses SARS-CoV-2, HKU1 and OC43

S. Soltani
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (12): 6482-6483
DOI: 10.26355/eurrev_202006_21629

Reply Letter – COVID-19 (Novel Coronavirus 2019) – Recent trends

S. Kannan, P. Shaik Syed Ali Pakeer, A. Sheeza Ali, K. Hemalatha
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (12): 6480-6481
DOI: 10.26355/eurrev_202006_21628

The complement inhibitors in COVID-19: future expectations

Y. Korotchaeva, N. Kozlovskaya, L. Bobrova, E. Kamyshova, K. Demyanova, S. Moiseev
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (12): 6478-6479
DOI: 10.26355/eurrev_202006_21626

How to restructure the management of Italian oncological patients during and after COVID-19 pandemic?

A. Fabi, G. Ferretti, F. Cognetti
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (10): 5830-5841
DOI: 10.26355/eurrev_202005_21378

COVID-19: a conundrum to decipher

V. Deshmukh, S.C. Tripathi, A. Pandey, V. Deshmukh, J. Vykoukal, A. Patil, B. Sontakke
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (10): 5819-5829
DOI: 10.26355/eurrev_202005_21377

An update on novel COVID-19 pandemic: a battle between humans and virus

S. Prajapati, M. Sharma, A. Kumar, P. Gupta, G.V. Narasimha Kumar
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (10): 5813-5818
DOI: 10.26355/eurrev_202005_21376

Is visiting Qom spread CoVID-19 epidemic in the Middle East?

N. Al-Rousan, H. Al-Najjar
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (10): 5810-5812
DOI: 10.26355/eurrev_202005_21375

Representation of specialties in Coronavirus Disease 2019 (COVID-19) research: analysis of published literature in the first 3 months

J. Robles, G. Aggarwal, S. Aggarwal
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (10): 5797-5809
DOI: 10.26355/eurrev_202005_21374

Clinical characteristics of two human-to-human transmitted coronaviruses: Corona Virus Disease 2019 vs. Middle East Respiratory Syndrome Coronavirus

P. Xu, G.-D. Sun, Z.-Z. Li
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (10): 5788-5796
DOI: 10.26355/eurrev_202005_21373

Viral kinetics and factors associated with rapid viral clearance during lopinavir/ritonavir-based combination therapy in non-severe COVID-19 patients

J.-G. Ding, J. Li, L. Hong, X.-Q. Yu, E.-L. Ye, G.-Q. Sun, X.-X. Zhang, L. Chen, Q.-F. Sun
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (10): 5783-5787
DOI: 10.26355/eurrev_202005_21372

Tocilizumab in the treatment of a critical COVID-19 patient: a case report

L. Wang, X. Peng, Z.-H. Wang, J. Cai, F.-C. Zhou
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (10): 5778-5782
DOI: 10.26355/eurrev_202005_21371

Standardized out-patient diagnosis and treatment process for osteoporosis clinics during the COVID-19 pandemic

J. Zou, D.-W. Song, J.-J. Niu, J.-W. Shi, H.-L. Yang
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (10): 5772-5777
DOI: 10.26355/eurrev_202005_21370

No infectious risk of COVID-19 patients with long-term fecal 2019-nCoV nucleic acid positive

Q.-X. Wang, K.-C. Huang, L. Qi, X.-H. Zeng, S.-L. Zheng
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (10): 5769-5771
DOI: 10.26355/eurrev_202005_21369

Severe acute dried gangrene in COVID-19 infection: a case report

E. Novara, E. Molinaro, I. Benedetti, R. Bonometti, E.C. Lauritano, R. Boverio
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (10): 5758-5768
DOI: 10.26355/eurrev_202005_21368

Impact of reimbursement limits on patient access to direct-acting antivirals in Italy: analysis of data from national registries

P. Russo, L. Pani, T. Staniscia, F. Romano, M. Marzioni
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (10): 5197-5198
DOI: 10.26355/eurrev_202005_21299

The impact of heroin illicit market in the framework of COVID 19 pandemic

E. Marinelli
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (10): 5195-5196
DOI: 10.26355/eurrev_202005_21298

Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?

A. Di Stadio, A. Della Volpe, M. Ralli, G. Ricci
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (10): 5193-5194
DOI: 10.26355/eurrev_202005_21297

Editorial – Sofosbuvir/Velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents

A. Izzi, V. Messina, L. Rinaldi, P. Maggi
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (9): 5189-5191
DOI: 10.26355/eurrev_202005_21218

Editorial – COVID-19 and the microbiota: new kids on the block

G. Gasbarrini, T. Dionisi, F. Franceschi, A. Gasbarrini
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (9): 5186-5188
DOI: 10.26355/eurrev_202005_21217

SARS-CoV-2 identification in lungs, heart and kidney specimens by transmission and scanning electron microscopy

M. Pesaresi, F. Pirani, A. Tagliabracci, M. Valsecchi, A.D. Procopio, F.P. Busardò, L. Graciotti
Free PDF Download